New perspectives in diabetic neuropathy.

Area of Science:

• Neuroscience
• Endocrinology
• Metabolic Diseases

Background:

• Rising global prevalence of Type 2 Diabetes (T2D) and its complications.
• Diabetic Peripheral Neuropathy (DPN) as a common microvascular complication of T2D.
• DPN characterized by length-dependent peripheral nerve damage and distal-to-proximal symptomatology.

Purpose of the Study:

• To review the pathogenesis of DPN, focusing on impaired metabolism and bioenergetics failure in peripheral nerves.
• To elucidate the roles of hyperglycemia, obesity, and dyslipidemia in DPN development.
• To discuss glia-axon interactions and novel therapeutic approaches for DPN.

Main Methods:

• Review of existing literature on DPN pathogenesis.
• Analysis of the impact of metabolic factors (hyperglycemia, dyslipidemia) on nerve bioenergetics.
• Examination of peripheral nerve anatomy and glia-axon dynamics in T2D.

Main Results:

• DPN results from impaired metabolism and bioenergetics failure in long peripheral nerve axons.
• Hyperglycemia, obesity, and dyslipidemia are key contributors to DPN pathogenesis.
• Glia-axon interactions are critical in the context of T2D-induced nerve injury.

Conclusions:

• Understanding the complex interplay of metabolic factors and nerve biology is crucial for DPN.
• Current therapies for DPN are limited, highlighting the need for mechanism-based treatments.
• Further research into novel therapeutic strategies targeting bioenergetics and glia-axon interactions is warranted.